Global Pediatric Orphan Drug Market Growth 2024-2030

Global Pediatric Orphan Drug Market Growth 2024-2030

Orphan drug development is crucial for children, who are disproportionately affected by rare diseases.

The global Pediatric Orphan Drug market size is projected to grow from US$ 75900 million in 2024 to US$ 150080 million in 2030; it is expected to grow at a CAGR of 12.0% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Pediatric Orphan Drug Industry Forecast” looks at past sales and reviews total world Pediatric Orphan Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Pediatric Orphan Drug sales for 2024 through 2030. With Pediatric Orphan Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Orphan Drug industry.

This Insight Report provides a comprehensive analysis of the global Pediatric Orphan Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Orphan Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pediatric Orphan Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Orphan Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Orphan Drug.

United States market for Pediatric Orphan Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Pediatric Orphan Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Pediatric Orphan Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Pediatric Orphan Drug players cover Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Orphan Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Others

Segmentation by Application:
0-1 Years
1-3 Years
3-6 Years
6-12 Years
＞ 12 Years

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pediatric Orphan Drug market?

What factors are driving Pediatric Orphan Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pediatric Orphan Drug market opportunities vary by end market size?

How does Pediatric Orphan Drug break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.